Over the past 20 years, and particularly in the last decade, significant developmental
milestones have driven basic, translational, and clinical advances in the field of stem cell …

Ischemic stroke is a leading cause of death worldwide. A key secondary cell death
mechanism mediating neurological damage following the initial episode of ischemic stroke …

In this review, we discuss the migration and homing ability of mesenchymal stem cells
(MSCs) and MSC‐like cells and factors influencing this. We also discuss studies related to …

Abstract Background Mesenchymal stromal cells (MSCs) are attractive for cell-based
therapies ranging from regenerative medicine and tissue engineering to immunomodulation …

Mesenchymal stem/stromal cells (MSCs) can regenerate tissues by direct differentiation or
indirectly by stimulating angiogenesis, limiting inflammation, and recruiting tissue-specific …

Mesenchymal stem cells (MSCs) are multipotent adult stem cells present in all tissues, as
part of the perivascular population. As multipotent cells, MSCs can differentiate into different …

Mouse and human fibroblasts were the first cell types successfully reprogrammed by ectopic
expression of OCT4, SOX2, KLF4, and c-MYC (OSKM)(Lowry et al., 2008; Maherali et al …

Human mesenchymal stem cells (hMSCs), which conventionally are isolated based on their
adherence to plastic, are heterogeneous and have poor growth and differentiation, limiting …

Mesenchymal stromal cells (MSCs) are rare progenitor cells that can be isolated from
various tissues. They exhibit multilineage differentiation potential, support regenerative …

Accumulating laboratory studies have implicated the mobilization of bone marrow (BM)-
derived stem cells in brain plasticity and stroke therapy. This mobilization of bone cells to the …